Package 67457-153-09

{"route": ["INTRAVENOUS"], "spl_id": "bd9c578c-322f-41fc-936d-bf9b551a2782", "openfda": {"unii": ["976728SY6Z"], "rxcui": ["1663224", "1663244", "1663248"], "spl_set_id": ["fcc8658c-761a-443f-8c32-1499d86028ec"], "manufacturer_name": ["Mylan Institutional LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, GLASS in 1 CARTON (67457-153-03)  / 3 mL in 1 VIAL, GLASS (67457-153-00)", "package_ndc": "67457-153-03", "marketing_start_date": "20021015"}, {"sample": false, "description": "10 VIAL, GLASS in 1 CARTON (67457-153-09)  / 9 mL in 1 VIAL, GLASS (67457-153-99)", "package_ndc": "67457-153-09", "marketing_start_date": "20040105"}, {"sample": false, "description": "1 VIAL, GLASS in 1 CARTON (67457-153-18)  / 18 mL in 1 VIAL, GLASS", "package_ndc": "67457-153-18", "marketing_start_date": "20031114"}], "brand_name": "Amiodarone Hydrochloride", "product_id": "67457-153_bd9c578c-322f-41fc-936d-bf9b551a2782", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antiarrhythmic [EPC]", "Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "67457-153", "generic_name": "amiodarone hydrochloride", "labeler_name": "Mylan Institutional LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amiodarone Hydrochloride", "active_ingredients": [{"name": "AMIODARONE HYDROCHLORIDE", "strength": "50 mg/mL"}], "application_number": "ANDA076217", "marketing_category": "ANDA", "marketing_start_date": "20021014", "listing_expiration_date": "20261231"}